Center for Infectious Disease Research and Policy

Connect with Us


  • Novel Coronavirus

  • Ebola

  • MERS-CoV

  • Chronic Wasting Disease

    Stewardship / Resistance Scan for Feb 14, 2020

    BD announces contract to help fight AMR in developing countries


    In a related development, the medical technology company BD (Becton, Dickinson and Co.) yesterday announced a $6 million contract with the Fleming Fund, the British aid program that helps low- and middle-income countries fight antimicrobial resistance.

    Under the contract, BD said it will provide diagnostic equipment and informatics systems to help diagnose infections and guide physicians to prescribe and use antibiotics appropriately. The company is based in Franklin Lakes, New Jersey.

    More than 70 labs in 19 countries will be provided with equipment to quickly detect bacteria and fungi in clinical specimens and blood and to test antimicrobial susceptibility, along with products for microbiology data management, the company said in its press release.

    The program is funded by the United Kingdom Department of Health and Social Care.

    "The Fleming Fund works to support 24 countries in the development of AMR surveillance systems, using the World Health Organization's 'One Health' approach," the BD release said. "One of the core activities for the Fleming Fund country grant program is to strengthen clinical bacteriology laboratories in order to identify and perform antimicrobial susceptibility testing (AST) on priority pathogens."
    Feb 13 BD press release

    UK partners with Nigeria to battle antimicrobial resistance

    The United Kingdom yesterday announced the launch of a partnership with Nigeria, worth £10.7 million, to fight antimicrobial resistance (AMR) by improving public health surveillance, upgrading laboratory equipment, and training technicians.

    The program will be operated by the Fleming Fund, a UK Aid program that helps low- and middle-income countries battle AMR, the fund said in a news release. The fund is managed by the UK Department of Health and Social Care in partnership with Mott McDonald, the fund's grant management agent.

    The Fleming Fund has appointed Development Alternatives Incorporation (DAI) to support Nigeria's AMR surveillance system, in collaboration with the Nigerian AMR coordination committee and other partners.

    Project activities in Nigeria to date include investment in 18 laboratories across the country and the appointment of 10 professional fellows who are being trained in data management, microbiology, epidemiology, and biosafety to help fight AMR, according to the release.
    Feb 13 Fleming Fund press release